Abstract
#Vascularendothelial growth factor (VEGF)-A is well known to be
involved in the #pathogenesis of #diabetic #nephropathy. Although it may be
a promising therapeutic target, recent evidence that anti-VEGF therapy
induces renal #thromboticmicro-angiopathy has tempered interest in its
use. We discuss the necessary conditions for future VEGF-targeting
therapy against diabetic nephropathy.
VEGF-Targeting Strategies against #Diabetic #Nephropathy: Obsolete or Still Promising? by Katsuyuki Tanabe in BJSTR
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.